SCHEMBL3187183

SCHEMBL3187183

COC(=O)/C=C/C=C/C(C)(C)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.47
PKM P14618 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAOB P27338 3/20 0.46
NR4A2 P43354 2/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
NR4A1 P22736 1/20 0.45
NR4A3 Q92570 1/20 0.45
SMPD1 P17405 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.44
HIF1A Q16665 1/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
PTPN1 P18031 1/20 0.43
GPR132 Q9UNW8 2/20 0.42
BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3187190 1.00 CACNA1B (0.47) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3180928 0.92 CACNA1B (0.50) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3180937 0.92 CACNA1B (0.50) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3205494 0.90 PKM (0.55) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3205501 0.90 PKM (0.55) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3580376 0.88 PKM (0.49) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL3580379 0.88 PKM (0.49) CACNA1BPKMKDM4EALDH1A1MAOB
SCHEMBL13282768 0.83 CACNA1B (0.46) CACNA1BALDH1A1SMPD1
SCHEMBL13254884 0.80 ALDH1A1 (0.55) KDM4EALDH1A1
SCHEMBL11165811 0.78 MAOB (0.53) CACNA1BPKMKDM4EALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168108-A1 PHENYL DERIVATIVES AND METHODS OF USE ADOLOR CORPORATION (US) 2010-07-01 US disclosed
US-20100168108-A1 PHENYL DERIVATIVES AND METHODS OF USE ADOLOR CORPORATION (US) 2010-07-01 US disclosed
US-7671052-B2 Phenyl derivatives and methods of use ADOLOR CORPORATION (US) 2010-03-02 US disclosed
US-7671052-B2 Phenyl derivatives and methods of use ADOLOR CORPORATION (US) 2010-03-02 US disclosed
US-20060074086-A1 Phenyl derivatives and methods of use ADOLOR CORPORATION (US) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074086-A1 Phenyl derivatives and methods of use CNR2, CNR1, GPR119 CACNA1B 2055/4885PKM 844/4885KDM4E 2264/4885
US-20100168108-A1 PHENYL DERIVATIVES AND METHODS OF USE CNR2, CNR1, GPR119 CACNA1B 2055/4885PKM 844/4885KDM4E 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.